Effect of cranberry supplement on long-term consequences of metabolic syndrome
Not Applicable
- Conditions
- metabolic syndrome.Personal history of endocrine, nutritional and metabolic diseases
- Registration Number
- IRCT201110192480N2
- Lead Sponsor
- Shiraz university of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
Women with features of metabolic syndrome between 20 and 50 years of age, BMI>25. Exclusion criteria: Postmenopausal women; medications for any chronic disease (cancer, diabetes, CVD); use of medication known to affect lipid metabolism or possess anti-inflammatory effect; Smoking; Alcohol consumption; use of supplements (antioxidants, multivitamins,...); Chronic disease: renal, liver, thyroid, etc; pregnant or lactating; use of warfarin.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ipid profile. Timepoint: Before and 2 months after intervention. Method of measurement: Auto analyzer.;FBS. Timepoint: Before and 2 months after intervention. Method of measurement: Auto analyzer.;Systolic and diastolic blood pressure. Timepoint: Before and 2 months after intervention. Method of measurement: Mercury Barometer.;Waist circumference. Timepoint: Before and 2 months after intervention. Method of measurement: Tape Meter.
- Secondary Outcome Measures
Name Time Method Insulin. Timepoint: Before and 2 months after intervention. Method of measurement: ELISA kit.;Interlukin-6 (IL-6). Timepoint: Before and 2 months after intervention. Method of measurement: RIA.;HsCRP. Timepoint: Before and 2 months after intervention. Method of measurement: ELISA kit.;Adiponectin. Timepoint: Before and 2 months after intervention. Method of measurement: ELISA kit.;Malon-dialdehide(MDA). Timepoint: Before and 2 months after intervention. Method of measurement: Spectrophotometry.